Cargando…

Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases

BACKGROUND: Ethmoid or sphenoid intestinal-type adenocarcinomas (ITACs) form a distinct subtype of sinonasal adenocarcinomas that occur less than 1 case/100,000/yr. They have obvious exposure relationship to hardwood or leather dusts, infrequent metastasis, but a relatively high local-recurrence rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ethan I., Lu, Ang, Tsai, Yao-Te, Wang, Ting-Chung, Chuang, Huei-Chieh, Chen, Wen-Cheng, Chen, Ping-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500565/
https://www.ncbi.nlm.nih.gov/pubmed/34622832
http://dx.doi.org/10.1097/MD.0000000000027341
_version_ 1784580474155302912
author Huang, Ethan I.
Lu, Ang
Tsai, Yao-Te
Wang, Ting-Chung
Chuang, Huei-Chieh
Chen, Wen-Cheng
Chen, Ping-Tsung
author_facet Huang, Ethan I.
Lu, Ang
Tsai, Yao-Te
Wang, Ting-Chung
Chuang, Huei-Chieh
Chen, Wen-Cheng
Chen, Ping-Tsung
author_sort Huang, Ethan I.
collection PubMed
description BACKGROUND: Ethmoid or sphenoid intestinal-type adenocarcinomas (ITACs) form a distinct subtype of sinonasal adenocarcinomas that occur less than 1 case/100,000/yr. They have obvious exposure relationship to hardwood or leather dusts, infrequent metastasis, but a relatively high local-recurrence rate. They locate at sinuses close to vital structures listed as high-risk areas in surgeries. Even in expert hands, a craniofacial resection is associated with non-negligible mortality and morbidity. Management of these tumors, first or recurrent, needs to weigh these consequences versus the survival, regional-recurrence, and distant-recurrence rates. Due to the rareness of ethmoid or sphenoid ITACs, accurate overall survival and local- or regional-recurrence rates across diverse treatments are unclear. The aim of this study is to report the overall statistics of this cancer and the relationship between enrollment year versus age, recurrence, and survival. METHODS: Systemic review and meta-analysis with 1126 cases across various treatments in the literature. RESULTS: Here, we show that patients of ethmoid or sphenoid ITACs had overall local-, regional-, and distant-recurrence rates of 32.2%, 2.2%, and 10.3%, respectively, with a 5-year overall survival rate of 66.2%. The results present a significant correlation between age, local-recurrent rate, or overall survival rate versus enrollment year. CONCLUSION: This suggests that recent patients of ethmoid or sphenoid ITACs may present at an older mean age, have a lower local-recurrence rate, and have a better 5-year survival rate than before. There was a shifting trend of treating ethmoid ITACs from external approach to endoscopic resection. Clinicians may want to weigh mortality and morbidity rates of external surgeries and these data to share or decide a solution.
format Online
Article
Text
id pubmed-8500565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85005652021-10-12 Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases Huang, Ethan I. Lu, Ang Tsai, Yao-Te Wang, Ting-Chung Chuang, Huei-Chieh Chen, Wen-Cheng Chen, Ping-Tsung Medicine (Baltimore) 6000 BACKGROUND: Ethmoid or sphenoid intestinal-type adenocarcinomas (ITACs) form a distinct subtype of sinonasal adenocarcinomas that occur less than 1 case/100,000/yr. They have obvious exposure relationship to hardwood or leather dusts, infrequent metastasis, but a relatively high local-recurrence rate. They locate at sinuses close to vital structures listed as high-risk areas in surgeries. Even in expert hands, a craniofacial resection is associated with non-negligible mortality and morbidity. Management of these tumors, first or recurrent, needs to weigh these consequences versus the survival, regional-recurrence, and distant-recurrence rates. Due to the rareness of ethmoid or sphenoid ITACs, accurate overall survival and local- or regional-recurrence rates across diverse treatments are unclear. The aim of this study is to report the overall statistics of this cancer and the relationship between enrollment year versus age, recurrence, and survival. METHODS: Systemic review and meta-analysis with 1126 cases across various treatments in the literature. RESULTS: Here, we show that patients of ethmoid or sphenoid ITACs had overall local-, regional-, and distant-recurrence rates of 32.2%, 2.2%, and 10.3%, respectively, with a 5-year overall survival rate of 66.2%. The results present a significant correlation between age, local-recurrent rate, or overall survival rate versus enrollment year. CONCLUSION: This suggests that recent patients of ethmoid or sphenoid ITACs may present at an older mean age, have a lower local-recurrence rate, and have a better 5-year survival rate than before. There was a shifting trend of treating ethmoid ITACs from external approach to endoscopic resection. Clinicians may want to weigh mortality and morbidity rates of external surgeries and these data to share or decide a solution. Lippincott Williams & Wilkins 2021-10-08 /pmc/articles/PMC8500565/ /pubmed/34622832 http://dx.doi.org/10.1097/MD.0000000000027341 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6000
Huang, Ethan I.
Lu, Ang
Tsai, Yao-Te
Wang, Ting-Chung
Chuang, Huei-Chieh
Chen, Wen-Cheng
Chen, Ping-Tsung
Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title_full Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title_fullStr Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title_full_unstemmed Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title_short Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases
title_sort decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: systematic review and meta-analysis with 1126 cases
topic 6000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500565/
https://www.ncbi.nlm.nih.gov/pubmed/34622832
http://dx.doi.org/10.1097/MD.0000000000027341
work_keys_str_mv AT huangethani decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT luang decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT tsaiyaote decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT wangtingchung decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT chuanghueichieh decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT chenwencheng decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases
AT chenpingtsung decreasingrecurrenceandincreasingsurvivalratesinpatientsofethmoidorsphenoidintestinaltypeadenocarcinomassystematicreviewandmetaanalysiswith1126cases